What future opportunities may immuno-oncology provide for improving the treatment of patients with lung cancer? (Q27012886)

PubMed

page(s)

viii28-34

1 reference

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

PubMed

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS260

Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS260

The noninvasive staging of non-small cell lung cancer: the guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS260

Role of genotyping in non-small cell lung cancer treatment: current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS260

Second-line Treatment for Non–Small-Cell Lung Cancer: One Size Does Not Fit All

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS260

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS260

American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS260

Target therapies in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS260

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS260

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS260

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS260

Long-Term Survival for Patients With Non–Small-Cell Lung Cancer With Intratumoral Lymphoid Structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS260

Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS260

Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS260

A high number of CD8+ T cells infiltrated in NSCLC tissues is associated with a favorable prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS260

The anticancer immune response: indispensable for therapeutic success?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS260

Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS260

Vaccines for the treatment of non-small cell lung cancer: a renewed anticancer strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS260

Cancer-testis genes are coordinately expressed and are markers of poor outcome in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS260

Intratumoral neoadjuvant immunotherapy using IL-12 and dendritic cells is an effective strategy to control recurrence of murine hepatocellular carcinoma in immunosuppressed mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS260

L-BLP25: a peptide vaccine strategy in non small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS260

Phase 2 trial of talactoferrin in previously treated patients with metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS260

Lactoferrin accelerates reconstitution of the humoral and cellular immune response during chemotherapy-induced immunosuppression and bone marrow transplant in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS260

Recombinant human lactoferrin prevents NSAID-induced intestinal bleeding in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS260

Recombinant human lactoferrin ingestion attenuates indomethacin-induced enteropathy in vivo in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS260

PD-1 and its ligands in tolerance and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS260

Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS260

Clinical Experiences With Anti-CD137 and Anti-PD1 Therapeutic Antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS260

Role of PD-1 in Regulating T-Cell Immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS260

Programmed death-1 upregulation is correlated with dysfunction of tumor-infiltrating CD8+ T lymphocytes in human non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS260

Immune Checkpoint Proteins: A New Therapeutic Paradigm for Cancer—Preclinical Background: CTLA-4 and PD-1 Blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS260

Anti-cytotoxic T-lymphocyte antigen-4 antibody: the first in an emerging class of immunomodulatory antibodies for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS260

Twenty-seven years of phase III trials for patients with extensive disease small-cell lung cancer: disappointing results

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS260

release_bvfmpljrujetzewlxn47ksocg4

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDS260

0 references

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bvfmpljrujetzewlxn47ksocg4

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed publication ID

22918925

1 reference